Sarah Cannon is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.
Sarah Cannon has participated in 21 clinical trials with 4 currently active.
Therapeutic areas: Ovarian Cancer, Advanced Colorectal Cancer, Advanced Solid Tumors With HER2 Abnormalities.
Sponsors: Ellipses Pharma, Daiichi Sankyo, Taiho Oncology, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Nashville
Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon has 21 clinical trials on record, with 4 currently active. Their work covers Ovarian Cancer, Advanced Colorectal Cancer, Advanced Solid Tumors With HER2 Abnormalities.
Sarah Cannon has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.